
Cohance Lifesciences Investor Relations Material
Latest events

Q4 24/25
Cohance Lifesciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cohance Lifesciences Limited
Access all reports
Suven Pharmaceuticals Limited is a pharmaceutical company engaged in the development, manufacturing, and supply of active pharmaceutical ingredients (APIs) and intermediates. The company primarily focuses on contract development and manufacturing services (CDMO) for global pharmaceutical companies, supporting drug discovery and commercial production. Its operations include process research, custom synthesis, and scale-up of complex molecules for use in various therapeutic areas. Suven Pharmaceuticals Limited serves clients across regulated and emerging markets. The company is headquartered in Hyderabad, India, and its shares are listed on the NSE.
Key slides for Cohance Lifesciences Limited


Q4 24/25
Cohance Lifesciences Limited


Q4 24/25
Cohance Lifesciences Limited
Latest articles
)
Nintendo: From Game Boy and Pokémon to Switch 2 and Mario Kart
Nintendo went from card maker to cultural icon, shaping modern entertainment through hardware innovation and world-famous characters.
19 Jun 2025
)
Ron Vachris: From Forklift Driver to CEO at Costco
Ron Vachris took over as Costco CEO in 2024, following a 40-year journey from warehouse floors to the top of one of retail's most admired companies.
18 Jun 2025
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
Ticker symbol
COHANCE
Country
🇮🇳 India